NCT06215235 Implementation of Bright Light Therapy ID
| NCT ID | NCT06215235 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Erasmus Medical Center |
| Condition | Depressive Symptoms |
| Study Type | OBSERVATIONAL |
| Enrollment | 105 participants |
| Start Date | 2023-10-18 |
| Primary Completion | 2025-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 105 participants in total. It began in 2023-10-18 with a primary completion date of 2025-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Many adults with intellectual disabilities (ID) have depressive symptoms, which negatively impact their quality of life. A lot of of the non-medicinal forms of treatment are not or hardly suitable for people with ID. Bright light therapy (BLT) seems to be a good option. Earlier research has shown that BLT is applicable in this group and seems promising in terms of reducing depressive symptoms, without serious side effects. In part 1 of this project we investigate the implementation of BLT at Amarant. We will take the lessons learned into part 2 of this project: the implementation of BLT at Abrona. We will evaluate this process and the outcomes.
Eligibility Criteria
Inclusion Criteria: * Involved in the implementation of BLT (staff) OR * Involved in the prescription or application of BLT (staff/relatives) OR * receiving BLT for their depressive symptoms (patients with ID) * 18 years or older * informed consent Exclusion Criteria: * n/a
Frequently Asked Questions
Who can join the NCT06215235 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Depressive Symptoms. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06215235 currently recruiting?
Yes, NCT06215235 is actively recruiting participants. Visit ClinicalTrials.gov or contact Erasmus Medical Center to inquire about joining.
Where is the NCT06215235 trial being conducted?
This trial is being conducted at Rotterdam, Netherlands.
Who is sponsoring the NCT06215235 clinical trial?
NCT06215235 is sponsored by Erasmus Medical Center. The trial plans to enroll 105 participants.